Atlas Venture Life Science Advisors, LLC Q1 2025 Filing
Filed May 14, 2025
Portfolio Value
$521.8B
Holdings
13
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (13 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KYMRKymera Therapeutics, Inc. | 4,896,462 | $134.0B | 25.69% | |
| 2 | IRONDisc Medicine, Inc. | 2,384,456 | $118.4B | 22.69% | |
| 3 | DYNDyne Therapeutics, Inc. | 9,130,465 | $95.5B | 18.30% | |
| 4 | DAWNDay One Biopharmaceuticals, Inc. | 6,430,257 | $51.0B | 9.77% | |
| 5 | SIONSionna Therapeutics, Inc. | 3,694,020 | $38.6B | 7.41% | |
| 6 | THRDThird Harmonic Bio, Inc. | 10,402,286 | $36.1B | 6.92% | |
| 7 | KRROKorro Bio, Inc. | 1,137,149 | $19.8B | 3.79% | |
| 8 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $10.4B | 1.99% | |
| 9 | —Ikena Oncology, Inc. | 5,018,178 | $6.4B | 1.23% | |
| 10 | AVTEAerovate Therapeutics, Inc. | 1,799,232 | $4.5B | 0.87% | |
| 11 | QTTBQ32 Bio, Inc. | 2,092,106 | $3.5B | 0.66% | |
| 12 | GBIOGBXGeneration Bio, Co. | 8,279,484 | $3.4B | 0.64% | |
| 13 | SPROSpero Therapeutics, Inc. | 305,255 | $219.8M | 0.04% |